Tumor suppression and potentiation by manipulation of pp32 expression.
about
Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cellsHMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme AThe role of LANP and ataxin 1 in E4F-mediated transcriptional repressionDifferential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform ACleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme AAnalysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4Cpd-1 null mice display a subtle neurological phenotypeThe crystal structure of the tumor suppressor protein pp32 (Anp32a): Structural insights into Anp32 family of proteinsMapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesispp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAsA new method to detect loss of heterozygosity using cohort heterozygosity comparisons.Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.pp32 reduction induces differentiation of TSU-Pr1 cells.ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylation.Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.Generation and characterization of LANP/pp32 null mice.HuR's role in gemcitabine efficacy: an exception or opportunity?Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia.PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis.Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis.A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brain.PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway.Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling.SET complex in serous epithelial ovarian cancer
P2860
Q22001541-08DE5DED-8490-4942-BF18-78EEFEEAFE39Q24292517-4A7782CA-3CE6-4FED-BAE3-C9AAE3167E10Q24308036-063EE296-612C-4E42-9DB4-1F338D1E369FQ24311360-BFFE66A2-9E29-4CFA-8341-123B7DF12D58Q24338600-D46175C9-D567-461C-ACE1-33B1BDFAE7DCQ24538586-20DF3C7B-DC30-4CD5-B663-FE8E2B4D4B93Q24633718-20289B64-614D-4E72-9088-343026E62AB8Q27320487-BFCB611B-045B-4DAC-9C12-EF66500729E8Q27645802-68F6A026-A9C4-4CC2-AF8E-FE3CA1A9F7D6Q28179296-777CC061-E6DF-476E-8C49-9CCECB88C912Q28476402-46D9FDC7-9458-4F1D-A3AC-44C29A682B23Q33576286-7C39E4AC-E27C-4A7F-97AD-98B0526B9636Q34730329-D41BFDCF-0489-4AD3-BBBA-DE2340683C31Q35083306-F3DCC68F-06F4-42CB-9D7A-32FA87B3D68DQ36847561-6BB8602B-E6EE-4DB2-B073-DA918B218C1FQ36998120-99C97911-E082-4E8B-A09B-2E86E4BCDAF9Q37277403-8723A192-9B4A-43F0-843E-1033FF9F7FD3Q37940426-68EA5A31-5E7F-4E82-9718-445D329B78F5Q40074127-72EDA819-FB91-42A5-86C0-A71F3B40252FQ42181561-C56C2D71-F8FF-4033-9733-1A43A32EF691Q45269798-AD3D2496-9CC5-46F8-B581-F00A6B4E61C5Q48291880-EF540011-F387-4868-8BD8-AB6567ECE7EEQ52581030-3386C87F-34F4-49E8-91CD-2F94FF317842Q54788103-FE3B9425-648C-453E-AEF1-A2AC322E08FAQ58325223-717246CE-A511-4514-856D-509B96E467DB
P2860
Tumor suppression and potentiation by manipulation of pp32 expression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tumor suppression and potentiation by manipulation of pp32 expression.
@ast
Tumor suppression and potentiation by manipulation of pp32 expression.
@en
type
label
Tumor suppression and potentiation by manipulation of pp32 expression.
@ast
Tumor suppression and potentiation by manipulation of pp32 expression.
@en
prefLabel
Tumor suppression and potentiation by manipulation of pp32 expression.
@ast
Tumor suppression and potentiation by manipulation of pp32 expression.
@en
P2093
P2860
P356
P1433
P1476
Tumor suppression and potentiation by manipulation of pp32 expression.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204294
P407
P577
2001-04-01T00:00:00Z
P5875
P6179
1001572839